Sign in
4

Changes in Ownership

Matinas BioPharma Holdings, Inc. Filed Acc 0001493152-23-045170

Options or other derivatives

  • President and CEO acquired 3,500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jabbour Jerome D President and CEO 2023-12-15 Grant or award · Stock Option (right to Buy) +3,500,000 3,500,000 D
Loading xslF345X05/ownership.xml…